Table 1 Basic information and clinical features
of
64 cases of COVID-19 in Wenzhou |
Table 1 Basic information and
clinical features
of
64 cases of COVID-19 in Wenzhou |
Characteristics |
Value |
Total |
64 |
Age(year)
Median
|
|
|
44 |
≤20 |
1/64(1.56%) |
20-60 |
58/64(90.63%) |
≥60 |
5/64(7.81%) |
Gender |
|
Male |
36/64(56.25%) |
Female |
28/64(43.75%) |
Generation |
|
1 (been to Wuhan in last 14 days) |
33/64(51.56%) |
2
(close contact to 1) |
25/64(39.06%) |
3 (close contact to 2) |
6/64(9.38%) |
Severity |
|
Light |
51/64(79.69%) |
Severe |
11/64(17.19%) |
Critical |
2/64(3.12%) |
Latency(62 cases had close contact history)(days) |
Latency(62
cases had close contact history)(days) |
Mean of latency |
3.44 |
Longest latency |
14 |
Shortest latency |
1 |
Discharge (till Feb 14) |
20 |
Of Light |
13/51(25.49%) |
Of Severe |
6/11(54.55%) |
Of Critical |
1/2(50%) |
Average hospital stay(day) |
21.1 |
Triple therapy (Interferon, Lopinavir/ritonavir, Abidor) |
8
days/course |
Glucocorticoid |
9/64(14.06%) |
Antibiotic use |
19/64(29.69%) |
Average of course of antibiotic use(days) |
8 |
Average of PCR transform to negative(days) |
12.8 |
Temperature (℃) (Mean±SD) |
38.1±0.85**
|
Fever |
59/64
(92.19%) |
Weakness |
39/64 (60.9%) |
Muscular soreness |
5/64 (7.8%) |
Lung Symptoms (by Chest Computer Tomographic) |
62/64
(96.9%) |
Pneumonia |
62 |
Lungs involvement (Both) |
61 |
Ground-glass opacity |
48 |
Consolidation |
42 |
Respiratory Symptoms |
45/64
(70.3%) |
Dry Cough |
41 |
Cough and expectoration |
23 |
Shortness of breath |
18 |
Pharyngalgia |
10 |
Bloody phlegm |
4 |
Nasal obstruction |
4 |
Yellow spectrum |
3 |
Gastrointestinal symptoms |
28/64
(43.8%) |
Diarrhea |
14 |
Nausea |
13 |
Vomit |
8 |
No symptoms (including no fever) |
|
Secondary infection |
15 |
Basic disease |
27/64 |
Smoke |
None |
Hypertension |
20/64 |
Chronic Liver disease |
7 |